These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 9616488)
1. Cell and molecular mechanisms of pathogenesis and treatment of cancer. Rew DA Postgrad Med J; 1998 Feb; 74(868):77-88. PubMed ID: 9616488 [TBL] [Abstract][Full Text] [Related]
2. Heterogeneity, biodiversity and bioperversity in solid neoplasms. Rew DA Eur J Surg Oncol; 1996 Oct; 22(5):469-73. PubMed ID: 8903487 [TBL] [Abstract][Full Text] [Related]
3. Tumour-microenvironmental interactions: paths to progression and targets for treatment. Box C; Rogers SJ; Mendiola M; Eccles SA Semin Cancer Biol; 2010 Jun; 20(3):128-38. PubMed ID: 20599506 [TBL] [Abstract][Full Text] [Related]
4. Overview of resistance to systemic therapy in patients with breast cancer. Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229 [TBL] [Abstract][Full Text] [Related]
6. Range Expansion Theories Could Shed Light on the Spatial Structure of Intra-tumour Heterogeneity. Gidoin C; Peischl S Bull Math Biol; 2019 Nov; 81(11):4761-4777. PubMed ID: 30535848 [TBL] [Abstract][Full Text] [Related]
7. Spatial and temporal cancer evolution: causes and consequences of tumour diversity. Hiley CT; Swanton C Clin Med (Lond); 2014 Dec; 14 Suppl 6():s33-7. PubMed ID: 25468916 [TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of metastatic disease: implications for current therapy and for the development of new therapeutic strategies. Poste G Cancer Treat Rep; 1986 Jan; 70(1):183-99. PubMed ID: 3510734 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of drug resistance in cancer chemotherapy. Luqmani YA Med Princ Pract; 2005; 14 Suppl 1():35-48. PubMed ID: 16103712 [TBL] [Abstract][Full Text] [Related]
12. [Advances in research on the molecular pathogenesis of the malignant tumours and implications for their early diagnosis and treatment]. Steffen J Med Wieku Rozwoj; 2000; 4(2 Suppl 2):11-25. PubMed ID: 11178325 [TBL] [Abstract][Full Text] [Related]
13. Tumour heterogeneity and drug resistance: personalising cancer medicine through functional genomics. Lee AJ; Swanton C Biochem Pharmacol; 2012 Apr; 83(8):1013-20. PubMed ID: 22192819 [TBL] [Abstract][Full Text] [Related]
14. Stem cells in the etiology and treatment of cancer. Zhang M; Rosen JM Curr Opin Genet Dev; 2006 Feb; 16(1):60-4. PubMed ID: 16377171 [TBL] [Abstract][Full Text] [Related]
16. A new model for oncogenesis. From tumour immunology to a mathematical approach of oncogenesis. Den Otter W; Koten JW; Derkinderen DJ Anticancer Res; 1986; 6(3 Pt B):509-14. PubMed ID: 3740800 [TBL] [Abstract][Full Text] [Related]
17. Italian cancer figures, report 2012: Cancer in children and adolescents. ; ; Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445 [TBL] [Abstract][Full Text] [Related]
18. Chemotherapy curable malignancies and cancer stem cells: a biological review and hypothesis. Savage P BMC Cancer; 2016 Nov; 16(1):906. PubMed ID: 27871274 [TBL] [Abstract][Full Text] [Related]
19. Targeted therapies of solid cancers: new options, new challenges. Awada A; Aftimos PG Curr Opin Oncol; 2013 May; 25(3):296-304. PubMed ID: 23493191 [TBL] [Abstract][Full Text] [Related]
20. High levels of X-linked Inhibitor-of-Apoptosis Protein (XIAP) are indicative of radio chemotherapy resistance in rectal cancer. Flanagan L; Kehoe J; Fay J; Bacon O; Lindner AU; Kay EW; Deasy J; McNamara DA; Prehn JH Radiat Oncol; 2015 Jun; 10():131. PubMed ID: 26071313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]